GB0919594D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0919594D0
GB0919594D0 GBGB0919594.2A GB0919594A GB0919594D0 GB 0919594 D0 GB0919594 D0 GB 0919594D0 GB 0919594 A GB0919594 A GB 0919594A GB 0919594 D0 GB0919594 D0 GB 0919594D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0919594.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0919594.2A priority Critical patent/GB0919594D0/en
Publication of GB0919594D0 publication Critical patent/GB0919594D0/en
Priority to PCT/EP2010/066962 priority patent/WO2011054947A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0919594.2A 2009-11-09 2009-11-09 Compounds Ceased GB0919594D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0919594.2A GB0919594D0 (en) 2009-11-09 2009-11-09 Compounds
PCT/EP2010/066962 WO2011054947A1 (en) 2009-11-09 2010-11-08 Thiadiazolidinedioxide p2x7 receptor antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0919594.2A GB0919594D0 (en) 2009-11-09 2009-11-09 Compounds

Publications (1)

Publication Number Publication Date
GB0919594D0 true GB0919594D0 (en) 2009-12-23

Family

ID=41502097

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0919594.2A Ceased GB0919594D0 (en) 2009-11-09 2009-11-09 Compounds

Country Status (2)

Country Link
GB (1) GB0919594D0 (en)
WO (1) WO2011054947A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014001454A2 (en) 2011-07-22 2017-06-27 Actelion Pharmaceuticals Ltd heterocyclic amide derivatives as p2x7 receptor antagonists
NZ628910A (en) 2012-01-20 2016-02-26 Actelion Pharmaceuticals Ltd Heterocyclic amide derivatives as p2x7 receptor antagonists
WO2014091415A1 (en) 2012-12-12 2014-06-19 Actelion Pharmaceuticals Ltd Indole carboxamide derivatives as p2x7 receptor antagonists
CN104854087B (en) 2012-12-18 2017-03-22 埃科特莱茵药品有限公司 Indole carboxamide derivatives as P2X7 receptor antagonists
WO2014115072A1 (en) 2013-01-22 2014-07-31 Actelion Pharmaceuticals Ltd Heterocyclic amide derivatives as p2x7 receptor antagonists
ES2616883T3 (en) 2013-01-22 2017-06-14 Actelion Pharmaceuticals Ltd. Heterocyclic amide derivatives as P2X7 receptor antagonists
WO2020227159A2 (en) 2019-05-03 2020-11-12 Flagship Pioneering Innovations V, Inc. Methods of modulating immune activity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133434A (en) 1997-04-28 2000-10-17 Glaxo Group Limited Purinergic receptor
SE0300445D0 (en) 2003-02-18 2003-02-18 Astrazeneca Ab New combination
EP1644041A1 (en) 2003-05-29 2006-04-12 AstraZeneca AB A pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine
RU2350354C2 (en) 2003-05-29 2009-03-27 Астразенека Аб PHARMACEUTICAL COMPOSITION, CONTAINING ANTAGONIST P2X7 OF RECEPTOR AND FACTOR OF TUMOUR NECROSIS α
US20070281931A1 (en) 2003-05-29 2007-12-06 Nigel Boughton-Smith Pharmaceutical Composition Containing a P2x7 Receptor Antagonist and Methotrexate
SE0302488D0 (en) 2003-09-18 2003-09-18 Astrazeneca Ab New combination
WO2006003517A1 (en) 2004-06-29 2006-01-12 Warner-Lambert Company Llc Combination therapies utilizing benzamide inhibitors of the p2x7 receptor
WO2006083214A1 (en) 2005-02-02 2006-08-10 Astrazeneca Ab Pharmaceutical composition comprising a p2x7 receptor antagonist and a hmg-coa reductase inhibitor
US20080207577A1 (en) 2005-07-11 2008-08-28 Astrazeneca Ab Combination I
WO2007008157A1 (en) 2005-07-11 2007-01-18 Astrazeneca Ab New combination 2
GB0724625D0 (en) * 2007-12-18 2008-01-30 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
WO2011054947A1 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
IL213992A0 (en) Pro-neurogenic compounds
IL215147A0 (en) Compounds
GB0907425D0 (en) Compounds
EP2393493A4 (en) Compounds
GB0918249D0 (en) Compounds
IL213019A0 (en) Azaazulene compounds
GB0914856D0 (en) Compounds
GB0922302D0 (en) Compounds
GB0905641D0 (en) Compounds
GB0909671D0 (en) Compounds
IL217049A0 (en) 3-phenoxymethylpyrrolidine compounds
GB0919594D0 (en) Compounds
GB0915519D0 (en) Ntithrombotic compounds
GB0909672D0 (en) Compounds
AP2909A (en) Pyrazinoisoquinoline Compounds
GB0911000D0 (en) Compounds
EP2443115A4 (en) Compounds
GB0905062D0 (en) Compounds
GB0915685D0 (en) Compounds
GB0908941D0 (en) Compounds
GB0906854D0 (en) Compounds
GB0909744D0 (en) Compounds
GB0909912D0 (en) Compounds
GB0910008D0 (en) Compounds
GB0910123D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)